Adrian Zaman

University Hospital Schleswig-Holstein

Papers

1

Total Citations

12

H-Index

1

About

Adrian Zaman is a leading figure in the emerging field of cardiac radioablation, where precision radiation therapy is repurposed to treat life-threatening arrhythmias. His most cited work, a multicenter, multiplatform benchmarking study for the RAdiosurgery for VENtricular TAchycardia (RAVENTA) trial, has already garnered 12 citations since its 2022 publication, establishing a critical foundation for standardizing treatment planning across institutions. Zaman’s primary contributions lie in bridging the gap between radiation oncology and cardiology, developing robust protocols that ensure safe and effective delivery of high-dose radiation to moving cardiac targets. By coordinating rigorous inter-institutional comparisons, he has helped validate the reproducibility of this novel technique, directly impacting clinical trial design and patient safety. His work is instrumental in transforming cardiac radioablation from a niche experimental approach into a reproducible, evidence-based therapy for ventricular tachycardia. For students and researchers, Zaman exemplifies how cross-disciplinary collaboration can pioneer non-invasive solutions for complex medical challenges, setting the stage for broader adoption of stereotactic body radiation therapy in cardiac care.

Research Focus

Key Achievements

1
H-Index
1
Papers
12
Total Citations
12
Avg Citations/Paper
🏆 Most Cited Paper
Treatment Planning for Cardiac Radioablation: Multicenter Multiplatform Benchmarking for the RAdiosurgery for VENtricular TAchycardia (RAVENTA) Trial
12 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 24
🏛 Institutions: University Hospital Schleswig-Holstein

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 10 days ago